Gilead Sciences
GILD
#131
Rank
C$225.36 B
Marketcap
C$181.51
Share price
3.26%
Change (1 day)
19.88%
Change (1 year)

Gilead Sciences (GILD) - Total liabilities

Total liabilities on the balance sheet as of March 2026 : C$46.62 Billion

According to Gilead Sciences's latest financial reports the company's total liabilities are C$46.62 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Gilead Sciences - Total liabilities on balance sheet (from 2001 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-12-31C$49.85 B-12.59%
2024-12-31C$57.03 B9.22%
2023-12-31C$52.22 B-8.28%
2022-12-31C$56.94 B-4.71%
2021-12-31C$59.75 B-6.62%
2020-12-31C$63.99 B25.7%
2019-12-31C$50.90 B-11.32%
2018-12-31C$57.40 B-8.28%
2017-12-31C$62.58 B23.82%
2016-12-31C$50.54 B11.76%
2015-12-31C$45.22 B106.81%
2014-12-31C$21.86 B89.63%
2013-12-31C$11.53 B-0.84%
2012-12-31C$11.63 B9.56%
2011-12-31C$10.61 B94.11%
2010-12-31C$5.46 B62.75%
2009-12-31C$3.36 B11.82%
2008-12-31C$3.00 B34.8%
2007-12-31C$2.22 B-13.65%
2006-12-31C$2.58 B200.22%
2005-12-31C$0.85 B151.11%
2004-12-31C$0.34 B-52.16%
2003-12-31C$0.71 B-36.78%
2002-12-31C$1.13 B107.6%
2001-12-31C$0.54 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Johnson & Johnson
JNJ
C$169.91 B 264.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
C$166.37 B 256.85%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
C$203.08 B 335.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$121.18 B 159.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$118.25 B 153.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
C$15.37 B-67.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
C$5.51 B-88.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
C$10.10 B-78.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$117.46 B 151.94%๐Ÿ‡บ๐Ÿ‡ธ USA